HHS IG Report On Part D: An Agenda Big Pharma Can Support
This article was originally published in RPM Report
The Inspector General report highlights rapid growth in compounded topical drugs paid for by Medicare. That is an area where most of the drug industry would be thrilled to see IG investigate.
Register for our free email digests: